PUMA BIOTECHNOLOGY INC's ticker is PBYI and the CUSIP is 74587V107. A total of 160 filers reported holding PUMA BIOTECHNOLOGY INC in Q2 2017. The put-call ratio across all filers is 1.25 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2020 | $340,000 | +83.8% | 33,664 | +90.2% | 0.10% | +222.6% |
| Q2 2020 | $185,000 | -87.0% | 17,700 | -89.1% | 0.03% | -76.7% |
| Q4 2019 | $1,419,000 | -58.4% | 162,141 | -48.8% | 0.13% | -54.8% |
| Q3 2019 | $3,407,000 | +1.9% | 316,474 | +20.4% | 0.29% | +12.2% |
| Q2 2019 | $3,342,000 | -16.0% | 262,945 | +34.4% | 0.26% | -15.5% |
| Q4 2018 | $3,980,000 | +430.7% | 195,589 | +2178.0% | 0.31% | +463.6% |
| Q2 2017 | $750,000 | -93.6% | 8,586 | -97.8% | 0.06% | -93.3% |
| Q2 2016 | $11,789,000 | +149.2% | 395,750 | +145.7% | 0.82% | +158.5% |
| Q1 2016 | $4,730,000 | -13.7% | 161,078 | +30.5% | 0.32% | -52.8% |
| Q2 2013 | $5,478,000 | – | 123,473 | – | 0.67% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| HARVARD MANAGEMENT CO INC | 600,000 | $45,216,000 | 3.56% |
| Avalon Global Asset Management LLC | 32,900 | $2,479,000 | 1.79% |
| CORNERSTONE CAPITAL MANAGEMENT LLC | 495,145 | $37,314,000 | 1.58% |
| BB BIOTECH AG | 521,991 | $39,337,000 | 1.25% |
| WEATHERBIE CAPITAL, LLC | 137,041 | $10,327,000 | 1.20% |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | 5,686,668 | $428,527,000 | 1.19% |
| TOBAM | 318,384 | $23,994,000 | 0.94% |
| Orbimed Advisors | 1,195,500 | $90,093,000 | 0.91% |
| Capital International Sarl | 109,405 | $8,245,000 | 0.74% |
| CAPITAL INTERNATIONAL LTD /CA/ | 145,697 | $10,980,000 | 0.73% |